...
首页> 外文期刊>Cost Effectiveness Resource Allocation >HTA and MCDA solely or combined? The case of priority-setting in Colombia
【24h】

HTA and MCDA solely or combined? The case of priority-setting in Colombia

机译:HTA和MCDA是单独使用还是组合使用?哥伦比亚确定优先事项的情况

获取原文
   

获取外文期刊封面封底 >>

       

摘要

BackgroundAll healthcare systems face problems of justice and efficiency related to setting priorities for allocating limited financial resources. Therefore, explicit decision-making in healthcare depicted as a continuum from evidence generation to deliberation and communication of the decision made, needs to be transparent and fair. Nevertheless, priority-setting in many parts of the world remains being implicit and ad-hoc process. Health Technology Assessment (HTA) and Multi-Criteria Decision Analysis (MCDA) have emerged as policy tools to assist informed decision-making. Both, MCDA and HTA have pros and cons. Main bodyColombia experienced an important institutional transformation after the establishment of the Health Technology Assessment Institute in 2012. This paper briefly presents the current challenges of the Colombian health system, the general features of the new health sector reform, the main characteristics of HTA in Colombia and the potential benefits and caveats of incorporating MCDA approaches into the decision-making process. ConclusionStructured and objective consideration of the factors that are both measurable and value-based in an open and transparent manner may be feasible through combining HTA and MCDA in contexts like Colombia. Further testing and validation of HTA and MCDA solely or combined in LMICs are needed to advance these approaches into healthcare decision-making worldwide.
机译:背景技术所有医疗保健系统都面临与确定分配有限财务资源的优先级有关的正义和效率问题。因此,在医疗保健中的明确决策是从证据生成到决策的讨论和交流的连续体,需要透明和公正。然而,在世界许多地方,确定优先次序仍然是隐含的临时过程。卫生技术评估(HTA)和多标准决策分析(MCDA)已成为协助知情决策的政策工具。 MCDA和HTA都有优点和缺点。主体哥伦比亚在2012年成立卫生技术评估研究所后经历了重要的机构转型。本文简要介绍了哥伦比亚卫生系统的当前挑战,新卫生部门改革的一般特征,哥伦比亚HTA的主要特征以及将MCDA方法纳入决策过程的潜在好处和警告。结论通过在哥伦比亚这样的背景下结合HTA和MCDA,以公开透明的方式对可测量和基于价值的因素进行结构化和客观的考虑可能是可行的。需要进一步测试和验证单独或组合在LMIC中的HTA和MCDA,以将这些方法推进全球医疗决策。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号